$5,000 Invested in These 2 Stocks Should Make You a Fortune Over the Next 10 Years

Make a fortune by putting money in these quality growth stocks driven by wonderful underlying businesses, including Couche-Tard (TSX:ATD.B).

| More on:

Investing in stocks implies you’re investing in their underlying businesses. Here are some proven businesses that have and will continue to beat the market in the long run.

Investing $5,000 in these growth stocks should make you a fortune over the next 10 years!

Make a fortune with this stable staples stock

Long-term investors can make a fortune with Alimentation Couche-Tard (TSX:ATD.B). The company acquired its way to success by consolidating the convenience store industry, which is still very fragmented!

Actually, Couche-Tard did more than just make deals and buy convenience stores. It also aimed to learn from and realize synergies from each acquisition.

Couche-Tard shareholders were very excited to hear about the company’s intentions to make yet another big acquisition, Caltex Australia, for A$8.8 billion, which “would have marked the largest acquisition in the country this year” according to Bloomberg.

Couche-Tard still thinks Caltex is a strategic fit for the company to span into Asia Pacific. However, after six months of due diligence, we arrive at a global pandemic situation that has impacted businesses everywhere, including convenience store chains.

As a result, Couche-Tard has decided to put a pause on the acquisition until the global outlook looks better. Notably, the substantial time and money that the company put into the due diligence process will not go to waste, as in the future, it will for sure revisit the acquisition.

Make a fortune with this growth stock

Brookfield Asset Management (TSX:BAM.A)(NYSE:BAM) stock is another ticket to riches. It is a leading alternative asset manager that invests in high-quality assets across more than 30 countries globally.

Additionally, these assets have a long life and are often cash cows that generate consistent cash flow in normal economic conditions.

The growth stock generates fee-related earnings and performance fees from the funds it manages. As well, it earns cash distributions from its investments in renewable energy and infrastructure assets, real estate, private equity, and credit.

BAM earns fee-related revenues from more than half of the US$540 billion of assets it manages. The company never has trouble raising capital. Investors, including institutional and private investors, keep coming back for more of what BAM offers — that is, long-term targeted returns of 12% or greater in top-notch real assets.

For example, in 2019, BAM raised more than US$27 billion of capital across its businesses. As Brookfield Asset Management manages more and more assets, it earns greater and greater fees. BAM is also heavily invested in its listed partnerships. So, rest assured that you are investing alongside owners that have the same interests!

BAM stock has fallen meaningfully by about 30% from its high. This year is a wonderful opportunity to accumulate the growth stock for wealth creation over decades.

The Foolish bottom line

COVID-19 will negatively impact the bottom lines of both Couche-Tard and BAM this year. However, investing $5,000 and holding the stocks for 10 years or longer should fetch you a fine fortune! Over 10 years, the stocks can roughly triple investors’ money, barring a market-wide downturn!

At about $39 per share, Couche-Tard is a reasonable value. I see the stock potentially trading in a sideways range for some time.

In any case, this year is a good time to accumulate shares in these wonderful companies, especially on meaningful dips.

Fool contributor Kay Ng owns shares of ALIMENTATION COUCHE-TARD INC and Brookfield Asset Management. The Motley Fool owns shares of and recommends Brookfield Asset Management. The Motley Fool recommends ALIMENTATION COUCHE-TARD INC and BROOKFIELD ASSET MANAGEMENT INC. CL.A LV.

More on Dividend Stocks

Person holding a smartphone with a stock chart on screen
Dividend Stocks

Enbridge Is Great, But I Think This Stock Could Be a Better Buy

Enbridge may be the safer dividend giant, but BCE’s beaten-down shares could offer the bigger rebound if its turnaround works.

Read more »

View of high rise corporate buildings in the financial district of Toronto, Canada
Dividend Stocks

1 Canadian Dividend Stock Down 24% to Buy and Hold Forever

Allied Properties REIT is down sharply from its highs. Here is why this Canadian dividend stock could still be worth…

Read more »

Colored pins on calendar showing a month
Dividend Stocks

What Your TFSA Could Look Like With $10,000 and Earning $41 in Monthly Income

CT REIT (TSX:CRT.UN) looks like the ultimate passive income play for Canadians in July and beyond.

Read more »

a person watches stock market trades
Dividend Stocks

Analysts Agree These Canadian Stocks Are Strong Buys

Three very different Canadian stocks are drawing rare agreement from Bay Street analysts, and each has a clear growth engine…

Read more »

Printing canadian dollar bills on a print machine
Dividend Stocks

How to Use Just $20,000 to Turn Your TFSA into a Reliable Cash-Generating Machine

Given their resilient business models, healthy cash flows, and attractive dividend yields, these two monthly dividend stocks are excellent choices…

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Dividend Stocks

Why Canadian Dividend ETFs Could Be the Simplest Way to Defend Your Portfolio

Dividend investing isn't a perfect strategy, but it's "good enough" for beginner investors.

Read more »

Doctor talking to a patient in the corridor of a hospital.
Dividend Stocks

A TFSA Pick Yielding 6.2% With Dependable Cash Payments

Vital Infrastructure Properties is a top TFSA stock that's benefitting from strong industry trends in healthcare real estate.

Read more »

a person prepares to fight by taping their knuckles
Dividend Stocks

1 Canadian Dividend Champion Down 15% for Lifetime Income

A beaten-down Canadian food dividend payer could reward patient investors with income today and a potential rebound tomorrow.

Read more »